MedPath

Prophylactic effect of colchincine and amiodarone

Phase 2
Completed
Conditions
Cardiology
Registration Number
PACTR202101651961317
Lead Sponsor
Tanta university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

•Patients undergoing elective coronary artery bypass surgery

Exclusion Criteria

• Emergency CABG.
•Patients with chronic renal failure as diagnosed by serum creatinine level above 200µmol/l.
•Patient undergoing CABG combined with valve surgery.
•Patients undergoing Re-Do CABG.
•Patients with history of atrial fibrillation determined by previous records.
• Patients with known hypersensitivity-allergy to colchicine or amiodarone.
•Under chronic treatment with colchicine or amiodarone.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.